APUS — Apimeds Pharmaceuticals US, Inc. · $2.4M cap

Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.

Use this APUS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the APUS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the APUS SEC filings page. Lician reads the product cache first so this HTML stays unique to Apimeds Pharmaceuticals US, Inc. even when a live quote feed is slow.

Apimeds Pharmaceuticals US, Inc. latest statements (FY2025)

Latest cached year on this hub. Full APUS income, balance, and cash tables.

  • Revenue$0
  • Net Income-$6.0M
  • Total Assets$164.2M
  • Total Debt$0
  • Free Cash Flow-$9.0M

APUS recent filings